Charles River Laboratories International, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2008 | $275.6M | $76.9M | $198.6M | $24.2M |
| FY2009 | $215.6M | $135.7M | $79.9M | $23.7M |
| FY2010 | $168.2M | $125.4M | $42.9M | $25.5M |
| FY2011 | $206.8M | $157.7M | $49.1M | $21.7M |
| FY2012 | $208.0M | $160.5M | $47.5M | $21.9M |
| FY2013 | $209.0M | $169.9M | $39.2M | $24.5M |
| FY2014 | $252.1M | $195.2M | $56.9M | $31.0M |
| FY2015 | $306.8M | $243.6M | $63.3M | $40.1M |
| FY2016 | $316.9M | $261.6M | $55.3M | $43.6M |
| FY2017 | $318.1M | $235.6M | $82.4M | $44.0M |
| FY2018 | $441.1M | $301.1M | $140.1M | $47.3M |
| FY2019 | $480.9M | $340.4M | $140.5M | $57.3M |
| FY2020 | $546.6M | $380.0M | $166.6M | $56.3M |
| FY2021 | $760.8M | $532.0M | $228.8M | $71.5M |
| FY2022 | $619.6M | $294.9M | $324.7M | $73.6M |
| FY2023 | $683.9M | $365.4M | $318.5M | $72.0M |
| FY2024 | $734.6M | $501.6M | $233.0M | $69.9M |
| FY2025 | $737.6M | $518.5M | $219.2M | $71.1M |